Fennec Pharmaceuticals (FENC) Interest & Investment Income (2010 - 2026)
Fennec Pharmaceuticals' Interest & Investment Income was $287,000 in Q2 2026, up 67.8% from $171,000 a year earlier.
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Interest & Investment Income (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Fennec Pharmaceuticals' Interest & Investment Income was $838,000 through Jun 30, 2026, down 36.6% year-over-year; for FY2025, it was $787,000, down 53.2% from FY2024.
- Interest & Investment Income shows a five-year compound annual growth rate of 55.3% (FY2020 to FY2025).
- In earlier years, Interest & Investment Income was $1.68 million in FY2024 (+281.4%), $441,000 in FY2023 (+126.2%), $195,000 in FY2022 (+261.1%) and $54,000 in FY2021 (-37.9%).
- The Q2 2026 figure marks the highest quarterly Interest & Investment Income since Q4 2024.
- Compared with a year earlier, Interest & Investment Income was higher in four of the last seven quarters, with growth averaging 79.6%.
- The best year-over-year quarter for Interest & Investment Income over five years was Q3 2024 (growth of 405.9%); the worst was Q3 2025 (a decline of 70.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Fennec Pharmaceuticals | 357.35 Mn | 238.66 Mn | 17.15 Mn | 287,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 287,000.00 |
| Dec 31, 2025 | 228,000.00 |
| Sep 30, 2025 | 152,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 236,000.00 |
| Dec 31, 2024 | 399,000.00 |
| Sep 30, 2024 | 516,000.00 |
| Jun 30, 2024 | 570,000.00 |
| Mar 31, 2024 | 197,000.00 |
| Dec 31, 2023 | 115,000.00 |
| Sep 30, 2023 | 102,000.00 |
| Jun 30, 2023 | 115,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | 153,000.00 |
| Sep 30, 2022 | 24,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 12,000.00 |
API Access
Fennec Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=FENC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "FENC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=FENC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();